Many blinding diseases involve loss of photoreceptor and retinal pigment epithelium (RPE) cells. Often, this cell death results from DNA aberrations, whether inherited or environmentally acquired. There are several biochemical and molecular processes for repairing DNA, in aggregate called the DNA Damage Response (DDR). The DDR is endogenously activated when damage is detected in genomic DNA. It can also be activated by experimentally inducing nonspecific or sequence-specific DNA damage. Unexpectedly, recent exciting developments show that the DDR can be activated even without DNA damage and that DDR activation with or without DNA damage can be a preconditioned, or protective, mechanism. Compared to non-differentiated cells, little is known about the DDR in terminally-differentiated cells such as those of the retina. This project is designed to increase our understanding of the endogenous DNA repair mechanisms of photoreceptor and RPE cells. By learning how DDR functions in retinal cells and how it can be activated experimentally, we can develop new strategies to enhance oligonucleotide-directed DNA repair, a gene therapy approach proven efficacious in retinal degeneration models in the previous funding period. Further, it may be that, analogous to hypoxic or cyclic light preconditioning, experimentally activating the DDR enhances the ability of retinal cells to withstand stresses that would otherwise lead to accumulation of DNA damage and death. Exploiting natural DNA repair processes thus could slow or prevent blindness by enhancing repair of specific gene mutations and by protecting retinal DNA from environmental insult.
The specific aims of this project are to test the hypotheses that: 1) DDR in retinal cells can be experimentally- activated and can enhance oligonucleotide-directed gene repair;and 2) experimentally-activated DDR is protective against subsequent DNA damage or its effects.
Many blinding diseases involve loss of photoreceptor and retinal pigment epithelium (RPE) cells due to DNA aberrations, whether inherited or acquired. There are several natural processes that cells possess to repair DNA damage, but little is known about these processes in retinal cells compared to other cells of the body. This project is designed to increase our understanding of the endogenous DNA repair mechanisms of retinal cells. By learning how these natural processes work in retinal cells, we may be able to increase their activities, prevent DNA damage or ameliorate its effects, and so slow or prevent blindness.
|Allen, Rachael S; Sayeed, Iqbal; Cale, Heather A et al. (2014) Severity of middle cerebral artery occlusion determines retinal deficits in rats. Exp Neurol 254:206-15|
|Lawson, Eric C; Han, Moon K; Sellers, Jana T et al. (2014) Aerobic exercise protects retinal function and structure from light-induced retinal degeneration. J Neurosci 34:2406-12|
|Jiang, Yi; Qi, X; Chrenek, Micah A et al. (2014) Analysis of mouse RPE sheet morphology gives discriminatory categories. Adv Exp Med Biol 801:601-7|
|Iuvone, P Michael; Boatright, Jeffrey H; Tosini, Gianluca et al. (2014) N-acetylserotonin: circadian activation of the BDNF receptor and neuroprotection in the retina and brain. Adv Exp Med Biol 801:765-71|
|Wright, Charles B; Chrenek, Micah A; Feng, Wei et al. (2014) The Rpe65 rd12 allele exerts a semidominant negative effect on vision in mice. Invest Ophthalmol Vis Sci 55:2500-15|
|Nickerson, John M; Getz, Shannon E; Sellers, Jana T et al. (2014) DNA delivery in adult mouse eyes: an update with corneal outcomes. Methods Mol Biol 1121:165-77|
|Tosini, Gianluca; Iuvone, Michael; Boatright, Jeffrey H (2013) Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma? J Glaucoma 22 Suppl 5:S49-50|
|Bhattacharya, Sanjoy K; Lee, Richard K; Grus, Franz H et al. (2013) Molecular biomarkers in glaucoma. Invest Ophthalmol Vis Sci 54:121-31|
|Jiang, Yi; Qi, Xin; Chrenek, Micah A et al. (2013) Functional principal component analysis reveals discriminating categories of retinal pigment epithelial morphology in mice. Invest Ophthalmol Vis Sci 54:7274-83|
|Wright, Charles B; Chrenek, Micah A; Foster, Stephanie L et al. (2013) Complementation test of Rpe65 knockout and tvrm148. Invest Ophthalmol Vis Sci 54:5111-22|
Showing the most recent 10 out of 21 publications